The Centre for Stem Cell Biology (CSCB) is recognized internationally as a Centre of Excellence for research on pluripotent stem cells. The research and discoveries of the CSCB are central to the long-term goal of developing clinical applications for pluripotent stem cells in regenerative medicine.
We were the first laboratory to undertake research on human embryonic stem cells in the UK in 1999 and have played a major role in training scientists in this dynamic field. The Centre complements the overall strength in Developmental Biology and Medicine at the University of Sheffield.
We coordinate the International Stem Cell Initiative, an international consortium of laboratories defining standards. It is also the main partner in ESTOOLS, an EU funded collaboration of researchers developing technologies for embryonic stem cells.
The expertise and excellent facilities of the CSCB represents a significant opportunity for collaborative activity with all organisations involved in pluripotent stem cell research.
Plasticell has announced that the Technology Strategy Board has funded a research consortium comprising of Plasticell, Pfizer (Neusentis) and the University of Sheffield, led by Cellzome. Read more.
The Centre for Stem Cell Biology is dismayed by the recent ruling by the European Court that patents involving human embryonic stem cells would be against public morality (C-34/10, Prof. Dr. Oliver Brüstle v Greenpeace e.V.) and therefore cannot be granted in the EU. Read more.
Co-Director of the Centre for Stem Cell Biology, Professor Peter Andrews was recently interviewed by Abcam at the recent conference:
'Rediscovering Pluripotency: From Teratocarcinomas to Embryonic Stem Cells'
10-12 October 2011
National Museum, Cardiff.